Bifalgorithm post · Cancer in 2026: How Immunotherapy Is Reshaping the Odds · Progress Is Real, But Uneven
Health Inequities
Health Inequities (Cancer in 2026: How Immunotherapy Is Reshaping the Odds · Progress Is Real, But Uneven) — "Racial and ethnic inequities persist – driven by…
Ideas in this flowchart
- Racial and ethnic inequities in cancer outcomes persist
- Systemic barriers drive these inequities
- Higher prevalence of risk factors
- Medical mistrust
- Lack of insurance hinders access to high-quality health care
- Survival gaps remain even after controlling for stage at diagnosis and socioeconomic status
- The largest contributor is less access to high-quality care across the cancer continuum
- Documented disparities across racial and ethnic groups
- Black men have prostate cancer death rates two to four times higher than other groups
- American Indians/Alaska Natives face double the mortality rates for kidney, liver, stomach, and cervical cancers
- Black women have uterine cancer death rates twice as high as White women
- Asian, Black, and Hispanic patients are less likely to receive recommended genetic testing, a gateway to targeted therapies